A carregar...
CC4-05: Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer
BACKGROUND/AIMS: ASCO provisional clinical guidelines (2009) recommend that patients with metastatic colon cancer (mCRC) be tested for mutations in the Kristen ras (KRAS) oncogene, and that those with a mutated KRAS gene (KRAS+) not be offered anti-epidermal growth factor receptor (EGFR) therapy as...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Marshfield Clinic
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421392/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2012.1100.cc4-05 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|